The humanistic burden of vitiligo: a systematic literature review of quality-of-life outcomes.
Journal
Journal of the European Academy of Dermatology and Venereology : JEADV
ISSN: 1468-3083
Titre abrégé: J Eur Acad Dermatol Venereol
Pays: England
ID NLM: 9216037
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
received:
12
10
2021
accepted:
04
03
2022
pubmed:
3
4
2022
medline:
23
8
2022
entrez:
2
4
2022
Statut:
ppublish
Résumé
Despite historical mischaracterization as a cosmetic condition, patients with the autoimmune disorder vitiligo experience substantial quality-of-life (QoL) burden. This systematic literature review of peer-reviewed observational and interventional studies describes comprehensive evidence for humanistic burden in patients with vitiligo. PubMed, EMBASE, Scopus and the Cochrane databases were searched through February 10, 2021, to qualitatively assess QoL in vitiligo. Two independent reviewers assessed articles for inclusion and extracted data for qualitative synthesis. A total of 130 included studies were published between 1996 and 2021. Geographical regions with the most studies were Europe (32.3%) and the Middle East (26.9%). Dermatology-specific instruments, including the Dermatology Life Quality Index (DLQI; 80 studies) and its variants for children (CDLQI; 10 studies) and families (FDLQI; 4 studies), as well as Skindex instruments (Skindex-29, 15 studies; Skindex-16, 4 studies), were most commonly used to measure humanistic burden. Vitiligo-specific instruments, including the Vitiligo-specific QoL (VitiQoL; 11 studies) instrument and 22-item Vitiligo Impact Scale (VIS-22; 4 studies), were administered in fewer studies. Among studies that reported total scores for the overall population, a majority revealed moderate or worse effects of vitiligo on patient QoL (DLQI, 35/54 studies; Skindex, 8/8 studies; VitiQoL, 6/6 studies; VIS-22, 3/3 studies). Vitiligo also had a significant impact on the QoL of families and caregivers; 4/4 studies reporting FDLQI scores indicated moderate or worse effects on QoL. In general, treatment significantly (P < 0.05) improved QoL, but there were no trends for types or duration of treatment. Among studies that reported factors significantly (P ≤ 0.05) associated with reduced QoL, female sex and visible lesions and/or lesions in sensitive areas were most common. In summary, vitiligo has clinically meaningful effects on the QoL of patients, highlighting that greater attention should be dedicated to QoL decrement awareness and improvement in patients with vitiligo.
Identifiants
pubmed: 35366355
doi: 10.1111/jdv.18129
pmc: PMC9790455
doi:
Types de publication
Journal Article
Review
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1507-1523Subventions
Organisme : Incyte Corporation
Informations de copyright
© 2022 Incyte Corporation. Journal of the European Academy of Dermatology and Venereology published by John Wiley & Sons Ltd on behalf of European Academy of Dermatology and Venereology.
Références
Int J Behav Med. 2018 Apr;25(2):243-251
pubmed: 28748378
Acta Derm Venereol. 2011 Mar;91(2):152-9
pubmed: 21240455
Clin Exp Dermatol. 2010 Oct;35(7):736-9
pubmed: 20015281
Acta Derm Venereol. 2008;88(5):474-9
pubmed: 18779885
Indian J Dermatol. 2016 Jan-Feb;61(1):99-100
pubmed: 26955110
J Clin Diagn Res. 2014 Jun;8(6):YC01-3
pubmed: 25121050
Indian J Dermatol Venereol Leprol. 2013 Mar-Apr;79(2):205-10
pubmed: 23442459
Br J Dermatol. 2012 Dec;167(6):1295-301
pubmed: 22897617
Dermatol Clin. 2021 Jan;39(1):117-127
pubmed: 33228855
Br J Dermatol. 2008 Nov;159(5):1186-91
pubmed: 18717675
Br J Dermatol. 2008 Aug;159(2):351-9
pubmed: 18565189
J Eur Acad Dermatol Venereol. 2021 Jan;35(1):216-221
pubmed: 32452565
Clin Cosmet Investig Dermatol. 2020 Aug 04;13:511-520
pubmed: 32801827
Trials. 2014 Feb 08;15:51
pubmed: 24507484
J Sex Marital Ther. 2016;42(3):267-76
pubmed: 25650731
J Am Acad Dermatol. 2006 Aug;55(2):238-44
pubmed: 16844505
Acta Derm Venereol. 2019 Feb 1;99(2):211-217
pubmed: 30307024
J Dermatolog Treat. 2017 Nov;28(7):668-671
pubmed: 28320220
Br J Dermatol. 2017 Dec;177(6):1764-1766
pubmed: 28872663
J Eur Acad Dermatol Venereol. 2020 Feb;34(2):392-399
pubmed: 31566833
Dermatology. 2016;232(5):619-625
pubmed: 27603174
J Dermatol. 2021 Mar;48(3):252-270
pubmed: 33404102
J Eur Acad Dermatol Venereol. 2007 Aug;21(7):942-50
pubmed: 17659004
Int J Dermatol. 2013 Jan;52(1):96-101
pubmed: 23278616
Indian J Dermatol. 2015 Mar-Apr;60(2):142-6
pubmed: 25814701
Photodermatol Photoimmunol Photomed. 2019 Jul;35(4):261-267
pubmed: 30854736
J Dermatolog Treat. 2014 Jun;25(3):196-9
pubmed: 23441902
Br J Dermatol. 1995 Jun;132(6):942-9
pubmed: 7662573
J Am Acad Dermatol. 2021 Nov;85(5):1321-1324
pubmed: 33022310
Acta Derm Venereol. 2015 May;95(5):553-8
pubmed: 25269389
BMC Dermatol. 2004 Aug 04;4:8
pubmed: 15294022
J Invest Dermatol. 2016 Jan;136(1):52-8
pubmed: 26763423
J Eur Acad Dermatol Venereol. 2011 Apr;25(4):429-35
pubmed: 20666878
Dermatology. 2009;218(2):151-4
pubmed: 19060458
An Bras Dermatol. 2012 May-Jun;87(3):361-8
pubmed: 22714749
G Ital Dermatol Venereol. 2013 Jun;148(3):255-61
pubmed: 23670062
Indian Dermatol Online J. 2019 Mar-Apr;10(2):153-157
pubmed: 30984590
Br J Dermatol. 2018 Jan;178(1):238-244
pubmed: 28391642
Arch Dermatol. 2008 Aug;144(8):1062-4
pubmed: 18711089
Dermatology. 2006;213(1):23-9
pubmed: 16778422
J Eur Acad Dermatol Venereol. 2022 Feb;36(2):279-285
pubmed: 34657353
Int J Dermatol. 2014 Jan;53(1):43-50
pubmed: 23692406
Kathmandu Univ Med J (KUMJ). 2019 Apr-Jun;17(66):114-118
pubmed: 32632057
Psychosom Med. 2004 Jul-Aug;66(4):620-4
pubmed: 15272112
Dermatology. 2005;210(4):279-85
pubmed: 15942213
An Bras Dermatol. 2015 May-Jun;90(3):358-62
pubmed: 26131866
Health Technol Assess. 2020 Nov;24(64):1-128
pubmed: 33245043
Br J Dermatol. 2008 Sep;159(4):915-20
pubmed: 18717679
Clin Exp Dermatol. 1994 May;19(3):210-6
pubmed: 8033378
J Eur Acad Dermatol Venereol. 2010 May;24(5):524-9
pubmed: 19807826
Arch Dermatol. 2007 May;143(5):578-84
pubmed: 17519217
Acta Derm Venereol. 2015 Mar;95(3):322-5
pubmed: 25110968
J Clin Nurs. 2012 Jun;21(11-12):1614-21
pubmed: 21771136
JAMA Dermatol. 2013 Feb;149(2):159-64
pubmed: 23560296
J Eur Acad Dermatol Venereol. 2015 Nov;29(11):2145-51
pubmed: 25868111
Ann Saudi Med. 2014 Mar-Apr;34(2):115-21
pubmed: 24894779
J Dermatol. 2009 Jun;36(6):317-22
pubmed: 19500179
Br J Dermatol. 2007 Mar;156(3):528-38
pubmed: 17300244
J Eur Acad Dermatol Venereol. 2005 Jan;19(1):56-60
pubmed: 15649192
West Afr J Med. 2020 Dec;37(7):745-749
pubmed: 33296482
Acta Derm Venereol. 2013 Jan;93(1):62-5
pubmed: 22859054
J Am Acad Dermatol. 2014 Nov;71(5):935-40
pubmed: 25218434
Indian J Dermatol Venereol Leprol. 2008 Nov-Dec;74(6):700
pubmed: 19177700
J Cosmet Dermatol. 2021 Jan;20(1):159-165
pubmed: 32406129
Br J Dermatol. 2018 Apr;178(4):863-878
pubmed: 28991357
An Bras Dermatol. 2011 Nov-Dec;86(6):1113-21
pubmed: 22281898
Med Care. 1999 Feb;37(2):126-39
pubmed: 10024117
Clin Exp Dermatol. 1996 Sep;21(5):330-3
pubmed: 9136149
Br J Dermatol. 2014 Aug;171(2):332-7
pubmed: 24665869
Eur J Dermatol. 2013 Sep-Oct;23(5):733-4
pubmed: 24126099
J Cosmet Dermatol. 2010 Mar;9(1):72-5
pubmed: 20367677
Actas Dermosifiliogr. 2017 Sep;108(7):637-642
pubmed: 28456327
Am J Clin Dermatol. 2021 Nov;22(6):757-774
pubmed: 34554406
J Am Acad Dermatol. 2013 Jul;69(1):e11-8
pubmed: 22365883
Indian J Dermatol Venereol Leprol. 2010 Sep-Oct;76(5):592
pubmed: 20827019
Gend Med. 2006 Jun;3(2):124-30
pubmed: 16860271
Br J Dermatol. 2015 Aug;173(2):607-9
pubmed: 25892476
Braz J Med Biol Res. 2016 Jul 25;49(8):
pubmed: 27464024
Br J Dermatol. 2005 Jul;153(1):163-6
pubmed: 16029343
Br J Dermatol. 2021 Jan;184(1):165-166
pubmed: 32726875
J Am Acad Dermatol. 2015 Nov;73(5):883-5
pubmed: 26475548
J Drugs Dermatol. 2017 Apr 1;16(4):344-350
pubmed: 28403268
JAMA Dermatol. 2017 Mar 1;153(3):341-342
pubmed: 28097309
Arch Dermatol Res. 2014 Apr;306(3):279-86
pubmed: 23982630
J Cutan Med Surg. 2015 Jan-Feb;19(1):50-6
pubmed: 25775664
Ann Dermatol. 2013 Nov;25(4):454-61
pubmed: 24371393
Br J Dermatol. 2005 Jun;152(6):1165-72
pubmed: 15948977
Br J Dermatol. 2010 Dec;163(6):1186-93
pubmed: 20804490
Dermatology. 2014;229(3):240-7
pubmed: 25358871
Dermatology. 2010;220(3):194-200
pubmed: 20203472
J Cosmet Dermatol. 2021 Jul;20(7):2232-2239
pubmed: 33089618
J Am Acad Dermatol. 2000 Feb;42(2 Pt 1):245-53
pubmed: 10642680
J Cutan Aesthet Surg. 2011 Jan;4(1):33-7
pubmed: 21572679
Int J Dermatol. 2012 Feb;51(2):158-61
pubmed: 22250623
Am J Clin Dermatol. 2016 Jun;17(3):305-11
pubmed: 26818062
Dermatol Clin. 2012 Apr;30(2):231-6, xiii
pubmed: 22284137
BMJ. 2009 Jul 21;339:b2535
pubmed: 19622551
Health Qual Life Outcomes. 2020 Feb 3;18(1):20
pubmed: 32013982
JAMA Dermatol. 2019 Aug 01;155(8):929-938
pubmed: 31141108
PLoS One. 2020 Jan 27;15(1):e0227909
pubmed: 31986193
Dermatol Surg. 2011 Feb;37(2):176-82
pubmed: 21269348
J Dtsch Dermatol Ges. 2016 Jan;14(1):45-9
pubmed: 26713637
JAMA Dermatol. 2017 Jul 1;153(7):666-674
pubmed: 28355423
J Am Acad Dermatol. 2022 May;86(5):1114-1116
pubmed: 33852927
Am J Clin Dermatol. 2013 Dec;14(6):489-95
pubmed: 23839260
Clin Exp Dermatol. 2021 Jun;46(4):669-674
pubmed: 33191544
Br J Dermatol. 2017 May;176(5):1170-1178
pubmed: 28032340
Br J Dermatol. 2009 Jul;161(1):134-9
pubmed: 19298268
G Ital Dermatol Venereol. 2012 Feb;147(1):83-90
pubmed: 22370571
J Am Acad Dermatol. 1996 Dec;35(6):895-8
pubmed: 8959947
Br J Dermatol. 2017 Dec;177(6):e338-e339
pubmed: 28869779
Br J Dermatol. 2003 Feb;148(2):373-4
pubmed: 12588405
J Am Acad Dermatol. 2017 Jul;77(1):1-13
pubmed: 28619550
Clin Exp Dermatol. 2021 Apr;46(3):510-515
pubmed: 32064670
Clin Exp Dermatol. 2011 Jun;36(4):360-5
pubmed: 21198786
Int J Nurs Pract. 2013 Sep;19 Suppl 3:3-10
pubmed: 24090292
Br J Dermatol. 2019 Mar;180(3):580-585
pubmed: 30085349
Br J Med Psychol. 1999 Sep;72 ( Pt 3):385-96
pubmed: 10524722
J Evid Based Complementary Altern Med. 2015 Oct;20(4):254-8
pubmed: 25851025
J Am Acad Dermatol. 2019 Nov;81(5):1107-1114
pubmed: 30763647
Br J Dermatol. 2013 Jan;168(1):5-19
pubmed: 22860621
Int J Dermatol. 2013 Feb;52(2):191-4
pubmed: 23347306
Pediatr Dermatol. 2014 May-Jun;31(3):309-18
pubmed: 24304125
J Patient Rep Outcomes. 2020 Mar 20;4(1):20
pubmed: 32193721
Health Qual Life Outcomes. 2016 Jun 07;14:86
pubmed: 27267598
BMC Neurol. 2017 Nov 22;17(1):202
pubmed: 29166883
Indian J Dermatol. 2018 Sep-Oct;63(5):399-402
pubmed: 30210161
Photodermatol Photoimmunol Photomed. 2020 Jan;36(1):14-20
pubmed: 31206787
Br J Dermatol. 2019 Mar;180(3):574-579
pubmed: 30030843
Br J Dermatol. 2014 Nov;171(5):1084-90
pubmed: 24805089
Eur J Cancer. 1996 May;32A(5):753-4
pubmed: 9081349
Actas Dermosifiliogr. 2017 Apr;108(3):244-252
pubmed: 28063525
J Invest Dermatol. 2021 Feb;141(2):265-273
pubmed: 32778407
J Am Acad Dermatol. 2009 Sep;61(3):411-20
pubmed: 19577331
J Invest Dermatol. 2015 Apr;135(4):970-974
pubmed: 25521460
J Eur Acad Dermatol Venereol. 2013 Nov;27(11):1344-51
pubmed: 23066663
Saudi Med J. 2007 Sep;28(9):1414-7
pubmed: 17768471
PLoS One. 2019 Jan 24;14(1):e0210581
pubmed: 30677057
Acta Derm Venereol. 2013 Jul 6;93(4):446-50
pubmed: 23306792
Dermatology. 2013;226(2):185-90
pubmed: 23735515
Acta Med Iran. 2012;50(7):511-5
pubmed: 22930385
Indian J Psychol Med. 2014 Jul;36(3):302-3
pubmed: 25035556
Dermatology. 2015;230(1):27-33
pubmed: 25613671
Br J Dermatol. 2009 Jul;161(1):128-33
pubmed: 19298280
J Eur Acad Dermatol Venereol. 2021 Mar;35(3):744-748
pubmed: 32893377
Int J Dermatol. 2005 Sep;44(9):736-42
pubmed: 16135141
Dermatol Res Pract. 2019 Apr 2;2019:6879412
pubmed: 31065260